A5096068819- Retinal Diseases and Treatments
- Retinal Imaging and Analysis
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
- Retinopathy of Prematurity Studies
- Ocular Diseases and Behçet’s Syndrome
- Retinal and Macular Surgery
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Cerebral Venous Sinus Thrombosis
- Dermatological and Skeletal Disorders
- Dermatologic Treatments and Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Laser Applications in Dentistry and Medicine
Vita-Salute San Raffaele University
2024-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2024-2025
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2024-2025
The purpose of the study is to characterize rate progression geographic atrophy (GA) areas in patients with age-related macular degeneration (AMD) subclinical angioid streaks (AS), compared AMD without AS. This a retrospective, longitudinal, case–control study. Among cohort AMD, we selected GA AS and followed them for 2-year follow-up. An age- sex-matched control group secondary was selected. Demographics differences between two groups were analyzed. 60 eyes affected by 20 (mean age 82 ± 5...
To analyze visual and anatomical outcomes in patients switched to brolucizumab previously treated with other intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents for exudative neovascular age-related macular degeneration (nAMD). These were was assessed the real-world setting of a tertiary center follow-up period 2 years. This retrospective longitudinal study included 29 eyes 24 nAMD at least three injections another anti-VEGF molecule. The then months following switch. A...
Purpose: To explore changes in reticular pseudodrusen (RPD) number and location after the development of macular neovascularization (MNV) eyes with prior intermediate age-related degeneration, focusing on different retinal regions differently affected by MNV. Methods: This retrospective longitudinal study included degeneration RPD that developed Reticular were assessed at baseline when MNV was diagnosed (MNV stage) anti–vascular endothelial growth factor treatment. Three interest considered:...
Purpose To evaluate photobiomodulation (PBM) safety and efficacy in patient with atrophic AMD to explore tissue effects using Spectrally Resolved Autofluorescence (SrAF) identify a potential biomarker indicative of mitochondrial activity, the primary PBM target. Methods This retrospective, non-comparative case series involved six eyes five patients AMD, conducted at Medical Retina Imaging Unit, IRCCS San Raffaele Hospital Milan, Italy. At baseline follow-ups (after one three months) complete...